PuSH - Publikationsserver des Helmholtz Zentrums München

Uda, N.R.* ; Seibert, V.* ; Stenner-Liewen, F.* ; Müller, P.* ; Herzig, P.* ; Gondi, G.* ; Zeidler, R. ; van Dijk, M.* ; Zippelius, A.* ; Renner, C.*

Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity.

J. Enzyme Inhib. Med. Chem. 30, 955-960 (2015)
DOI PMC
Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Carbonic anhydrase 9 (CA9) and carbonic anhydrase 12 (CA12) were proposed as potential targets for cancer therapy more than 20 years ago. However, to date, there are only very few antibodies that have been described to specifically target CA9 and CA12 and also block the enzymatic activity of their targets. One of the early stage bottlenecks in identifying CA9- and CA12-inhibiting antibodies has been the lack of a high-throughput screening system that would allow for rapid assessment of inhibition of the targeted carbon dioxide hydratase activity of carbonic anhydrases. In this study, we show that measuring the esterase activity of carbonic anhydrase offers a robust and inexpensive screening method for identifying antibody candidates that block both hydratase and esterase activities of carbonic anhydrase's. To our knowledge, this is the first implementation of a facile surrogate-screening assay to identify potential therapeutic antibodies that block the clinically relevant hydratase activity of carbonic anhydrases.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.332
0.686
22
20
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cancer Therapy ; Carbonic Anhydrase 9 & 12 ; Enzyme Inhibition ; High-throughput Screening ; Renal Cell Cancer; Renal-cell Carcinoma; Monoclonal-antibody; Intracellular Ph; Hydrophobic Pocket; Enzymatic-activity; Ix; Protein; Xii; Inhibitors; Hypoxia
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 1475-6366
e-ISSN 1475-6374
Quellenangaben Band: 30, Heft: 6, Seiten: 955-960 Artikelnummer: , Supplement: ,
Verlag Informa Healthcare
Verlagsort London
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501500-001
PubMed ID 25775095
Scopus ID 84946484631
Scopus ID 84940752579
Erfassungsdatum 2015-04-22